207 related articles for article (PubMed ID: 28457961)
21. Albumin-coated porous hollow poly(lactic-co-glycolic acid) microparticles bound with palmityl-acylated exendin-4 as a long-acting inhalation delivery system for the treatment of diabetes.
Kim H; Lee J; Kim TH; Lee ES; Oh KT; Lee DH; Park ES; Bae YH; Lee KC; Youn YS
Pharm Res; 2011 Aug; 28(8):2008-19. PubMed ID: 21472489
[TBL] [Abstract][Full Text] [Related]
22. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
23. Sustained release of matrix metalloproteinase-3 to trabecular meshwork cells using biodegradable PLGA microparticles.
Turturro S; Sunoqrot S; Ying H; Hong S; Yue BYJT
Mol Pharm; 2013 Aug; 10(8):3023-3032. PubMed ID: 23795867
[TBL] [Abstract][Full Text] [Related]
24. A biodegradable perivascular wrap for controlled, local and directed drug delivery.
Sanders WG; Hogrebe PC; Grainger DW; Cheung AK; Terry CM
J Control Release; 2012 Jul; 161(1):81-9. PubMed ID: 22561340
[TBL] [Abstract][Full Text] [Related]
25. A biomimetic approach to active self-microencapsulation of proteins in PLGA.
Shah RB; Schwendeman SP
J Control Release; 2014 Dec; 196():60-70. PubMed ID: 25219750
[TBL] [Abstract][Full Text] [Related]
26. Direct contact-mediated non-viral gene therapy using thermo-sensitive hydrogel-coated dressings.
Eltaher HM; Blokpoel Ferreras LA; Jalal AR; Dixon JE
Biomater Adv; 2022 Dec; 143():213177. PubMed ID: 36371970
[TBL] [Abstract][Full Text] [Related]
27. Delayed release of chemokine CCL25 with bioresorbable microparticles for mobilization of human mesenchymal stem cells.
Fröhlich K; Hartzke D; Schmidt F; Eucker J; Gurlo A; Sittinger M; Ringe J
Acta Biomater; 2018 Mar; 69():290-300. PubMed ID: 29408710
[TBL] [Abstract][Full Text] [Related]
28. Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics.
Tsai M; Lu Z; Wientjes MG; Au JL
J Control Release; 2013 Dec; 172(3):737-44. PubMed ID: 24056144
[TBL] [Abstract][Full Text] [Related]
29. Issues in long-term protein delivery using biodegradable microparticles.
Ye M; Kim S; Park K
J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
[TBL] [Abstract][Full Text] [Related]
30. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
[TBL] [Abstract][Full Text] [Related]
31. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere.
Park W; Kim D; Kang HC; Bae YH; Na K
Biomaterials; 2012 Dec; 33(34):8848-57. PubMed ID: 22959184
[TBL] [Abstract][Full Text] [Related]
32. Lipid and PLGA Microparticles for Sustained Delivery of Protein and Peptide Drugs.
Wu C; Mu H
Pharm Nanotechnol; 2020; 8(1):22-32. PubMed ID: 31663483
[TBL] [Abstract][Full Text] [Related]
33. Local delivery of controlled-release simvastatin/PLGA/HAp microspheres enhances bone repair.
Tai IC; Fu YC; Wang CK; Chang JK; Ho ML
Int J Nanomedicine; 2013; 8():3895-904. PubMed ID: 24143094
[TBL] [Abstract][Full Text] [Related]
34. Controlled release of anti-inflammatory siRNA from biodegradable polymeric microparticles intended for intra-articular delivery to the temporomandibular joint.
Mountziaris PM; Sing DC; Chew SA; Tzouanas SN; Lehman ED; Kasper FK; Mikos AG
Pharm Res; 2011 Jun; 28(6):1370-84. PubMed ID: 21184147
[TBL] [Abstract][Full Text] [Related]
35. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
[TBL] [Abstract][Full Text] [Related]
36. PLGA-Mesoporous Silicon Microspheres for the in Vivo Controlled Temporospatial Delivery of Proteins.
Minardi S; Pandolfi L; Taraballi F; De Rosa E; Yazdi IK; Liu X; Ferrari M; Tasciotti E
ACS Appl Mater Interfaces; 2015 Aug; 7(30):16364-73. PubMed ID: 26108253
[TBL] [Abstract][Full Text] [Related]
37. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.
Hu Y; Hollinger JO; Marra KG
J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815
[TBL] [Abstract][Full Text] [Related]
38. Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.
Hines DJ; Kaplan DL
Crit Rev Ther Drug Carrier Syst; 2013; 30(3):257-76. PubMed ID: 23614648
[TBL] [Abstract][Full Text] [Related]
39. Development of PLGA-based itraconazole injectable nanospheres for sustained release.
Bian X; Liang S; John J; Hsiao CH; Wei X; Liang D; Xie H
Int J Nanomedicine; 2013; 8():4521-31. PubMed ID: 24311942
[TBL] [Abstract][Full Text] [Related]
40. In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
Wu C; Luo X; Baldursdottir SG; Yang M; Sun X; Mu H
Eur J Pharm Biopharm; 2019 Sep; 142():315-321. PubMed ID: 31299277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
